This event has ended. Create your own event on Sched.
Welcome to the Science Summit at UNGA76, a major contribution to advancing Science for the UN SDGs. Online from 14- September - 5 October 2021.
ISC will organise the second edition of the UNGA76 Science Summit around the 76th United Nations General Assembly (SSUNGA76) in September 2021. The objective of the virtual meeting will be to raise awareness of the role and contribution of science to the attainment of the United Nations Sustainable Development Goals. It will demonstrate initiatives that provide models for global science mechanisms and activities in support of the SDGs, particularly in science infrastructure and capacity building. Science is and will enable sustainable economic, environmental, and societal development. Science is more than a funding prioritisation exercise: science is impacting all areas of policy-making and is playing a more critical role in how policy objectives are achieved and the consequent benefit to people everywhere, including responses to global challenges.
Engagement with policy leadership is more important than ever: UNGA76 is a unique forum for science to demonstrate how policy and political leadership can benefit from innovation. Central to this is the role of nonstate actors and the multilateral fora, which increasingly determine how priorities are set. Science needs to be part of this dialogue and inform outputs through thought leadership, evidence, insights, analysis, and innovation.

Registration is available here.
avatar for Jens Habermann

Jens Habermann

Biobanking and Biomolecular Resources Research Infrastructure (BBMRI ERIC)
Director General
Professor Jens K. Habermann, M.D., PhD, is the Director-General of BBMRI-ERIC (Biobanking and Biomolecular Resources Research Infrastructure – European Research Infrastructure Consortium) since September 2020. For his current position at BBMRI-ERIC, the University of Lübeck has granted him a leave of absence in official and public interest from his occupancies as Head of the Section of Translational Surgical Oncology and Biobanking and as Head of ICB-L (Interdisciplinary Center for Biobanking-Lübeck). Prof. Habermann obtained his M.D. training at the Medical University of Lübeck (Lübeck, Germany), received his PhD at the Cancer Center Karolinska, Karolinska Institute (Stockholm, Sweden) and a Postdoctoral Fellowship at the National Cancer Institute, NIH (Bethesda, USA).

As a board certified specialist in human genetics, Prof. Habermann combines clinics, biobanking, and translational (cancer) research to optimize precision medicine. Prof. Habermann was actively involved in the Molecular Tumor Board as part of the precision medicine program in Lübeck and a member of the Ethics Board of the University of Lübeck. Prof. Habermann was President of ESBB (European, Middle Eastern & African Society for Biopreservation & Biobanking; esbb.org) from 2018 to 2020 and board member of GBN/GBA (German Biobank Node and German Biobank Alliance; BBMRI.de).

Prof. Habermann received more than 15 scientific awards, holds about 10 patents and patent applications, is a reviewer and editorial board member of more than 25 scientific journals and member of numerous scientific societies. He has translational cancer research and biobanking related publication track record and was the principal investigator and co-PI in more than 21 national and European grant projects.